RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 36 - per page Next page
Order by
Two papers on Embil's novel triple-active topical products (Neo-Penotran® Forte and Neo-Penotran® Forte-L) have been accepted for presentation at the 4'th World Conference on Vaginitis, Costa Rica, 10-13 Jan 2004 More
Postec (TM) is more efficacious than isolated topical steroid in the non surgical treatment of phimosis in children and adults More
APR Applied Pharma Research will soon present results of the phase III efficacy trials with ketoprofen patch in the treatment of tendinites and ankle sprains at the annual meetings of the American College of Rheumatology and of the French Society of More
-- Breakthrough Chronotherapy Treatment for Hypertension Utilizes Eurand's Diffucaps® Technology -- More
ProEthic Laboratories, LLC and Applied Pharma Research have signed a licensing agreement for a once-daily transdermal version of ketoprofen, a member of the NSAID class of drugs that also includes the popular Celebrex and Vioxx brands. More
A new and unique service providing strategic and licensing support to biopharmaceutical and medical companies More
On January 15th 2003, the European Patent Office has granted final patent protection (EP 1275377A1) to APR's proprietary technology for the preparation of granulates containing liposoluble substances. More
The Swiss based Drug Delivery Company APR Applied Pharma Research has recently published very successful results on tissue absorption and distribution of ketoprofen TDS patch. More
LAB International Inc. today announced that it has entered into an agreement to purchase Focus Inhalation Oy of Turku, Finland. Principal vendors commit to co-invest EUR 4 million in Focus Inhalation. More
Displaying 1..10 of 36 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us